Patent details
EP2481405 Title: Nanoparticles of paclitaxel and albumin in combination with bevacizumab against cancer
Basic Information
- Publication number:
- EP2481405
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP121549950
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Nanoparticles of paclitaxel and albumin in combination with bevacizumab against cancer
- French Title of Invention:
- Nanoparticules anticancéreuses de paclitaxel et d'albumine en combinaison avec du bévacizumab
- German Title of Invention:
- Nanoteilchen von Paclitaxel und Albumin in Kombination mit Bevacizumab gegen Krebs
- SPC Number:
Dates
- Filing date:
- 06/11/2007
- Grant date:
- 23/03/2016
- EP Publication Date:
- 23/03/2016
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 01/08/2012
- EP B1 Publication Date:
- 23/03/2016
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 06/11/2027
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 11/03/2020
- Name:
- Abraxis BioScience, LLC
- Address:
- 86 Morris Avenue, Summit, New Jersey 07901, United States (US)
History of Owners
- From:
- 06/11/2007
- To:
- 11/03/2020
- Name:
- Abraxis BioScience LLC
- Address:
- 11755 Wilshire Boulevard, Suite 2100, Los Angeles, CA 90025, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 25/05/2016
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- Desai Neil P.
- Address:
- United States (US)
2
- Name:
- Soon-Shiong Patrick
- Address:
- United States (US)
Priority
- Priority Number:
- 594417
- Priority Date:
- 06/11/2006
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 31/337;
Publication
Bulletin
- Bulletin Heading:
- CO
- Bulletin edition number:
- 2020/05
- Publication date:
- 09/04/2020
- Description:
- Section M : Transfers of property (Art. 53 of the law), change of name and/or address
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Change of owner(s) name/address
- Deed Number:
- RC20200000075A
- Date Registered:
- 11/03/2020
- Licence Effective Date:
- Licence Expiration Date:
- Scope of Licence:
- Deed Filer:
- OFFICE FREYLINGER S.A.
- Journal Edition Number:
- Text:
- Changement d'adresse
- Country Code:
- Updated Licence Number:
- Terminated Licence Number:
Added Owner(s)
- Name:
- Abraxis BioScience, LLC
- Address:
- 86 Morris Avenue, Summit, New Jersey 07901, United States (US)
Removed Pledgee
- Name:
- Address:
Annual Fees
- Annual Fee Due Date:
- 30/11/2026
- Annual Fee Number:
- 20
- Annual Fee Amount:
- 300 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- 27/10/2025
- Last Annual Fee Paid Number:
- 19
- Last Annual Fee Paid Amount:
- 281 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM
| Filing date | Document type | Number of pages |
|---|---|---|
| 11/03/2020 | Request For Change | 1 |
| 12/03/2020 | Outgoing Correspondence | 1 |